HBMCX
Price
$19.76
Change
+$0.04 (+0.20%)
Updated
Sep 18 closing price
Net Assets
647.42M
RPMGX
Price
$97.30
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

HBMCX vs RPMGX

HBMCX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
HBMCX vs. RPMGX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBMCX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 20.8B vs. HBMCX (647M). HBMCX (0.00) and RPMGX (0.00) have matching dividends . HBMCX was incepted earlier than RPMGX: HBMCX (27 years) vs RPMGX (34 years). HBMCX (1.01) is less costly to investors than RPMGX (0.77). HBMCX is a more actively managed with annual turnover of: 60.00 vs. RPMGX (31.50). HBMCX has a lower initial minimum investment than RPMGX: HBMCX (0) vs RPMGX (2500). RPMGX annual gain was more profitable for investors over the last year : -5.63 vs. HBMCX (-14.31). RPMGX return over 5 years is better than : -24.20 vs. HBMCX (-47.87).
HBMCXRPMGXHBMCX / RPMGX
Total Expense Ratio1.010.77131%
Annual Report Gross Expense Ratio1.010.77131%
Fund Existence27 years34 years-
Gain YTD-7.0120.062-11,363%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets647M20.8B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.31-5.63254%
Returns for 3 years-16.06-0.198,654%
Returns for 5 years-47.87-24.20198%
Returns for 10 years-36.1727.75-130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX11.150.01
+0.09%
Goldman Sachs Mid Cap Growth A
JOHAX29.76-0.01
-0.03%
JOHCM International Select Investor
PRHSX94.44-0.31
-0.33%
T. Rowe Price Health Sciences
THMEX16.85-0.07
-0.41%
CCT Thematic Equity Institutional
BRSYX16.90-0.09
-0.53%
MFS Blended Research Small Cap Eq R6